Adrenal disorders encompass a spectrum of diseases affecting the adrenal glands, two small glands located atop the kidneys. These disorders can significantly alter hormonal balance, with implications for multiple body systems. This overview aims to enhance healthcare professionals' understanding of these complex conditions.
Adrenal disorders can be broadly categorized into disorders of hyperfunction, such as Cushing's syndrome and pheochromocytoma, and disorders of hypofunction, like Addison's disease. Adrenal incidentalomas, benign masses discovered incidentally, also warrant mention.
Diagnosis often involves a combination of clinical evaluation, biochemical testing, and imaging. Patients may present with a range of symptoms, from fatigue and weight changes in Addison's disease, to hypertension and hyperglycemia in Cushing's syndrome. Pheochromocytomas may cause paroxysmal hypertension and sweating.
Treatment strategies depend on the underlying disorder. Addison's disease typically requires lifelong hormone replacement, while Cushing's syndrome may necessitate surgery, medication, or radiation therapy. Pheochromocytomas are usually surgically removed. Management of adrenal incidentalomas depends on size, functionality, and growth rate.
Long-term management often involves monitoring for potential complications and adjusting treatment as necessary. Regular follow-up is essential to ensure therapeutic efficacy and monitor for disease progression or recurrence.
Adrenal disorders, while diverse in nature, share a common impact on hormonal balance and overall health. An understanding of these disorders, their clinical presentations, diagnostic approaches, and management strategies is crucial for healthcare professionals. This knowledge allows for accurate diagnosis, effective treatment, and comprehensive patient care in these complex conditions.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation